Cryo-Cell International, Inc. is collaborating with researchers all over the world on pre-clinical studies of Célle for potential future therapies that may possibly treat disorders such as diabetes; breast cancer and wound-healing etc...
Recently C'elle in 'Medical News Today' announced the results of a study on 'Stem Cells and Development' article. The study, entitled “Menstrual Blood Cells Display Stem Cell-Like Phenotypic Markers and Exert Neuroprotection Following Transplantation in Experimental Stroke” was conducted by researchers at Cryo-Cell International, the University of South Florida, Saneron-CCEL Therapeutics and the Medical College of Georgia. It shows that stem cells found in menstrual blood may one day be a potential source for stem cell therapies in stroke and other central nervous system disorders.
According to a number of early studies, Menstrual stem cells often known as MenSCs, offer an easily accessible, non-controversial and renewable stem cell source with the potential to one day treat a host of diseases, such as stroke, osteoporosis, Alzheimer's and Parkinson's disease to name a few.
Ever since introduced in November 2007, C’elle(SM) service is the first and only service that empowers women to collect and cryopreserve menstrual flow containing undifferentiated adult stem cells for future utilization by the donor or possibly their first-degree relatives in a manner similar to umbilical cord blood stem cells.
At present, Célle is offering a discount of $100 on the $499 retail price with a special limited time offer for collection, processing, testing and first year storage at $399. Use the code CLSTR.
No comments:
Post a Comment